The Underweight rating suggests that Barclays believes Agilent Technologies may underperform the broader market or its sector. However, the increase in the price target from $100 to $120 suggests a more positive outlook on the company's potential future performance. This mixed message may lead to a neutral short-term impact on the stock as investors weigh the negative rating against the higher price target.